Published August 14, 2023
Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a Fellow of the American College of Clinical Pharmacy (ACCP).
Fellowship in the American College of Clinical Pharmacy (FCCP) recognizes excellence in the practice and science of clinical pharmacy and is the highest honor ACCP can bestow on its members. It is awarded to individuals who have made sustained contributions to ACCP and who have demonstrated exceptional performance in clinical pharmacy practice or research.
“To be recognized as a Fellow of The American College of Clinical Pharmacy (ACCP) is truly humbling and an honor,” says Meaney. “It injects new vitality into my commitment to advancing clinical pharmacy and living up to the high standards of ACCP.”
Meaney has been a member of ACCP since 2009. His research is focused on the optimization of drug therapy through the application of quantitative clinical pharmacology. He leads a multidisciplinary group of researchers to address novel personalization of erythropoiesis-stimulating agents in hemodialysis patients. His other work has focused on drug-induced nephrotoxicity and the optimal use of antibacterials in hemodialysis.
As an educator, Meaney engages students through real-world application of pharmacotherapy using active learning techniques. He finds his personal interaction with students through advising and mentoring to be the most rewarding part of being a faculty member in the Department of Pharmacy Practice.
“ACCP is my professional ‘home’ as their mission and values align with mine,” says Meaney. “Their members are visionary leaders in clinical pharmacy whom I admire and respect.”
The mission of ACCP is to improve human health by extending the frontiers of clinical pharmacy through strategic initiatives, partnerships, collaborations and alliances.